Cochlear implants boosted by gene therapy plus tiny LEDs
By Clare Wilson,
New Scientist
| 07. 07. 2016
Can light restore hearing in deaf people? Researchers hope that through optogenetics, they can use micro-LED lights to make better cochlear implants than those used by deaf people today.
Standard cochlear implants function by stimulating nerves using an electrode placed inside the cochlea, a tiny spiral cavity inside the ear. These work, but sounds are distorted and muffled.
That’s because people who aren’t deaf can normally discriminate between about 2000 different sound frequencies, whereas cochlear implants allow only about a dozen to be distinguished. As a result, these implants make human speech sound a bit like that of a dalek, and music can be unpleasant.
Continue reading on New Scientist
Image via Flickr/Jessica Merz
Related Articles
By Erik Adams, Sundance | 09.08.2026
The scariest movie playing at the 2026 Sundance Film Festival isn’t about cursed audio recordings or a killer demon disguised as your true love; rather it’s a 110-minute essay film about how a handful of guys obsessed with numbers and...
By Gaia Ghirardi, Arno Van Hootegem & K. Paige Harden , Nature Human Behaviour | 09.21.2026
Embryo screening for behavioural traits is no longer speculative. If you want to become a parent in the USA today, you can pay to use pre-implantation polygenic testing (PGT-P) of in vitro fertilization (IVF)-created embryos. PGT-P promises to optimize offspring...
Artificial Intelligence (AI) has been a major focus of news recently, as it should have been, under the appropriately ridiculous name of Hugging Face, “a leading collaboration platform and community hub for machine learning, artificial intelligence, and data science.” In July, Hugging Face was hacked. The platform itself responded:
Earlier this week, we detected and responded to an intrusion into part of our production infrastructure. This one was different from anything we had handled before in one important way...
By Miryam Naddaf, Nature | 09.21.2026
A wave of epigenetic therapies is offering hope as ways to cure chronic hepatitis B — a lingering liver infection that is caused by the hepatitis B virus (HBV) and affects more than 250 million people around the world. Currently...
